CMPX FY 2025 Earnings — Compass Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

CMPXCompass Therapeutics, Inc.

$781M

FY 2025 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0-100.0% YoY

Gross Profit

$0

Operating Income

-$73M

Net Income

-$66M

EPS (Diluted)

$-0.42

Cash Flow

Operating Cash Flow

-$49M

Free Cash Flow

-$49M

Stock-Based Comp.

$8M

Balance Sheet

Total Assets

$220M

Total Liabilities

$23M

Stockholders' Equity

$197M

Cash & Equivalents

$31M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$850,000	-100.0%
Gross Profit	$0	$850,000	-100.0%
Operating Income	-$73M	-$57M	-28.6%
Net Income	-$66M	-$49M	-34.7%